SCHEMBL25488446

SCHEMBL25488446

Fc1ccc(C(CCCNCc2ccc3[nH]c4ccc(F)cc4c3c2)c2ccc(F)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VPS4B O75351 1/20 0.57
VCP P55072 1/20 0.57
NPSR1 Q6W5P4 2/20 0.46
CNR1 P21554 2/20 0.46
MITF O75030 1/20 0.46
LMNA P02545 1/20 0.46
CNR2 P34972 1/20 0.46
GPR35 Q9HC97 1/20 0.46
GPR55 Q9Y2T6 1/20 0.46
XBP1 P17861 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
MPO P05164 1/20 0.45
SLC6A4 P31645 1/20 0.45
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
MAPT P10636 1/20 0.43
SCN5A Q14524 1/20 0.43
CHRM2 P08172 1/20 0.42
DRD4 P21917 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24837125 0.73 VPS4B (1.00) VPS4BVCPSLC6A4
Bromide SCHEMBL11583932 0.67 SCN5A (0.55) VPS4BVCPNPSR1CNR1MITF
SCHEMBL29387074 0.66 ACHE (0.67) LMNAMAPK1HTTMPOMAPT
SCHEMBL15379639 0.66 ACHE (0.67) LMNAMAPK1HTTMPOMAPT
SCHEMBL20730852 0.65 CHRM2 (0.65) NPSR1CNR1MITFLMNACNR2
SCHEMBL31324156 0.65 KDM4E (0.81) LMNAHTTMEN1KMT2AMAPT
SCHEMBL11583277 0.64 HTR2A (0.69) NPSR1CNR1MITFLMNACNR2
SCHEMBL10045186 0.63 CHRM2 (0.88) LMNAMPOCHRM2ACHE
Hydrochloric Acid SCHEMBL9501139 0.62 SCN5A (0.53) LMNAMEN1KMT2ASCN5AFOLH1
Hydrochloric Acid SCHEMBL31087727 0.62 KDM4E (0.57) MITFMPOMEN1KMT2AKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230146923-A1 COMPOSITIONS AND METHODS FOR INHIBITION AND TARGETING OF P97 CALIFORNIA INST OF TECHN (US) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230146923-A1 COMPOSITIONS AND METHODS FOR INHIBITION AND TARGETING OF P97 HSP90B1, CDC37, HDLBP VPS4B 920/4885VCP 29/4885NPSR1 3859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.